Our analysis of cisplatin treatment in cholangiocarcinoma cell lines showed increased expression of several transporters involved in anticancer drug uptake, including hCNTs, hENTs and hOCT1. The gene discussed is SLC22A1; the disease is cholangiocarcinoma.